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Abstract  
Introduction: The association of adenocarcinoma found in the pancreas and stomach wall is a relatively rare condition as 
is any metastasis from the pancreas to the stomach.  Pancreatic carcinoma associated with additional gastric cancer is 
also relatively uncommon.  The most frequent sites of metastasis reported for pancreatic adenocarcinoma are the lymph 
nodes, lung, liver, adrenal glands, kidney, and bone.  We report a case of adenocarcinoma of the pancreas associated 
with a separate adenocarcinoma of the stomach wall.  Not enough research has been placed on properly distinguishing 
these two forms of malignancies.  
Presentation of Case: In this case report we discuss the presentation of an 87 year old female who presented with 
abdominal pain and was found to have multiple sites of metastasis of Adenocarcinoma of pancreatic origin with direct 
spread to the stomach wall.  
Conclusion: The characteristics of this combination of gastric and pancreatic adenocarcinoma, whether there is a direct 
correlation or through local metastasis, needs to be further investigated to shed light on this condition.   
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Introduction 
Similar to other malignancies, pancreatic cancer can spread either by directly invading local areas or by 
spreading through the bloodstream or lymphatic system to distant locations.  In our patient, pathology 
was unable to fully distinguish the primary site of the carcinoma but determined it to be of likely 
pancreatic origin.  Cases of synchronous carcinomas of the stomach and pancreas are relatively rare and 
similar to pancreatic adenocarcinoma with local metastasis to the stomach wall.  
Case presentation 
An 87 year old female with a past medical history of hypertension and hypothyroidism presented to the 
emergency room with a complaint of right upper quadrant abdominal pain of three day duration.  She 
underwent ultrasound which was suggestive but inconclusive for acute cholecystitis.  However, it 
incidentally discovered multiple masses in the liver, hilum/pancreatic head region, and left upper 
abdomen presumably representing a metastatic tumor.  CT scan of the abdomen was positive for 
multiple soft tissue masses adjacent to the liver hilum and pancreatic head, a large cystic mass on the 
posterior wall of the stomach, and a small low-attenuation lesion on the inferior right hepatic lobe 
representing metastasis (Figure 1).  Multiple lesions were further discovered within both kidneys either 
representing complex/hemorrhagic cysts or small enhancing lesions.  At the time of initial presentation, 
the patient refused any further testing including biopsy.  CEA level was found to be elevated at 40.4 
(0-4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: CT scan of the abdomen with multiple masses adjacent to liver hilum, pancreatic head, posterior 
wall of stomach, and inferior hepatic lobe. 
 
Patient returned to the hospital 6 months later with complaints of recurring abdominal right flank and 
back pain.  She denied any other associated symptoms.  On physical examination significant findings 
showed a blood pressure of 184/73 and only other significant finding was right flank tenderness. 
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Figure 2: CT scan demonstrating multiple sites of lymphadenopathy, new hepatic lesions, and a large 
mass at the tail of the pancreas and stomach 
 
 
 
 
Figure 3: Pathology significant for poorly differentiated Adenocarcinoma 
 
 
Repeat abdominal CT showed an increase in bulky lymphadenopathy in the perihepatic, peripancreatic, 
gastrohepatic region and new hepatic lesions as well as a large mass now at the tail of the pancreas and 
stomach (Figure 2).  Patient agreed for biopsy and pathology reported poorly differentiated 
adenocarcinoma positive for CD X2 and AE1/3 (Figure 3).  The results were nonspecific but suggested a 
likely primary source to be the pancreas, however an additional primary site of the stomach could not be 
excluded.  CEA level was found to have increased to 124.9 (0-4.7) and AFP was elevated at 10,889 
(0-8.3).  Patient refused any intervention at this time and was discharged to rehab with outpatient 
oncology follow up. 
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Discussion 
Pancreatic cancer carries a relatively poor prognosis and is well known to metastasize rapidly thus being 
one of the deadliest malignancies reported. Pancreatic cancer is the fourth leading cause of cancer death 
among men and women in the USA, making up about 6% of all cancer-related deaths [1].  In the 
literature there are many different sites of metastasis that are well documented.  The liver and peritoneum 
are the most common sites of metastases followed by the lungs, bone, and brain [2].  While less common 
sites are found to be present in the muscle, skin, pleura, heart, umbilicus, kidney, stomach, appendix, and 
even include the spermatic cord and prostate [2].  Some methods of metastasis of various tumors include 
direct invasion, lymphatic spread, hematogenous spread, or even chemotaxis invasion where cancer cells 
with high expression of chemokine receptor are able to spread to specific sites. Clinical symptoms and 
signs are unfortunately not present until the late stages of the disease when metastasis has already 
occurred.  
Pancreatic cancer has been associated with gastric cancer, however no report has directly mentioned 
any relationship between the direct spread of pancreatic adenocarcinoma to the stomach wall.  Due to 
the proximity of the pancreas to the stomach it brings into question whether direct invasion could be a 
mechanism of such a presentation.  This is different than a previously reported case of synchronous 
double cancer of the pancreas and stomach.  In one case report, the diagnosis and management with 
subtotal gastrectomy and distal pancreatectomy was made in a patient found to have moderately 
differentiated tubular adenocarcinoma of the stomach in addition to moderately differentiated tubular 
adenocarcinoma of the pancreas [3].  Pancreatic cancer associated with cancer of other organs is 
estimated to range from 7.3 to 16.7 percent while the presence of gastric cancer with pancreatic cancer 
specifically makes up only 3.8% of all gastric cancers [3-5]. 
In the final analysis of the pathology of this patient, she was found to be CDx2 positive but other tumor 
markers most commonly associated with Pancreatic Adenocarcinoma were negative.  The final 
pathology report concluded the biopsy was consistent with poorly differentiated adenocarcinoma of the 
GI tract likely correlating and stemming from the pancreas.  The stomach was another possible primary 
source of adenocarcinoma but CT demonstrated its presence limited to only the stomach wall.  These 
findings were unusual in the sense that the site of the cancer other than metastasis to the liver and lymph 
nodes, was otherwise limited only to the posterior wall of the stomach and pancreas.  Other reports in 
the literature fail to address how a direct connection between these two organs can result in the spread of 
adenocarcinoma to only a section of the outer wall of the stomach.  If the diagnosis was made at a later 
stage, it remains unclear whether the cancer would have invaded deeper into the stomach tissue. 
Conclusion 
Whether the source of the Adenocarcinoma was the stomach or the pancreas, the presentation of the 
cancer as a single lesion in both organs is a rare finding of multiple synchronous primary 
adenocarcinomas.  However the higher likelihood, as reported by pathology, has the pancreas labeled as 
the primary site of Adenocarcinoma which metastasized to not only the liver, lymph nodes, but also the 
stomach wall.  The finding of a posterior wall mass on the stomach is a rare finding, however it is 
significant because it is able to demonstrate some of the many presentations of Pancreatic cancer and its 
possible sites for metastasis.  If further investigations and diagnostic tools can be implemented on the 
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spread of Pancreatic cancer to such sites it may improve future survival rates.  Pancreatic cancer, which 
has a very high mortality rate, continues to be a difficult to treat condition as the rapidity and questionable 
method of invasion has not been researched and investigated.  The cancer being limited to the stomach 
wall demonstrates that the method of spread of Adenocarcinoma may involve local spread as no sign of 
internal metastasis was present.  As the patient refused further intervention, it still remains unclear how 
any intervention may impact the spread of the cancer but the presentation continues to shed light on the 
possible methods of invasions associated with Pancreatic cancer.   
Consent 
Informed consent was obtained by the patient prior to any research or discussion of this case. 
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